Vitiligo treatment gets positive CHMP opinion
European Pharmaceutical Review
FEBRUARY 24, 2023
The Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of ruxolitinib cream (Opzelura ) for non-segmental vitiligo with facial involvement in people over 12 years old. News : @EMA_News has issued a positive opinion for an Incyte-discovered therapy for patients with #vitiligo.
Let's personalize your content